Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
30 06 2020
Historique:
pubmed: 12 6 2020
medline: 18 7 2020
entrez: 12 6 2020
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses an immediate, major threat to public health across the globe. Here we report an in-depth molecular analysis to reconstruct the evolutionary origins of the enhanced pathogenicity of SARS-CoV-2 and other coronaviruses that are severe human pathogens. Using integrated comparative genomics and machine learning techniques, we identify key genomic features that differentiate SARS-CoV-2 and the viruses behind the two previous deadly coronavirus outbreaks, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), from less pathogenic coronaviruses. These features include enhancement of the nuclear localization signals in the nucleocapsid protein and distinct inserts in the spike glycoprotein that appear to be associated with high case fatality rate of these coronaviruses as well as the host switch from animals to humans. The identified features could be crucial contributors to coronavirus pathogenicity and possible targets for diagnostics, prognostication, and interventions.

Identifiants

pubmed: 32522874
pii: 2008176117
doi: 10.1073/pnas.2008176117
pmc: PMC7334499
doi:

Substances chimiques

Nuclear Localization Signals 0
Nucleocapsid Proteins 0
Spike Glycoprotein, Coronavirus 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15193-15199

Subventions

Organisme : NHLBI NIH HHS
ID : DP1 HL141201
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH110049
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Viruses. 2014 Aug 07;6(8):2991-3018
pubmed: 25105276
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
J Virol. 2005 Sep;79(17):11507-12
pubmed: 16103202
Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):15193-15199
pubmed: 32522874
J Gen Virol. 2005 Dec;86(Pt 12):3303-3310
pubmed: 16298975
Cell Res. 2013 Aug;23(8):986-93
pubmed: 23835475
EMBO Rep. 2000 Nov;1(5):411-5
pubmed: 11258480
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
J Virol. 2001 Oct;75(19):9345-56
pubmed: 11533198
Cell. 2020 Apr 16;181(2):223-227
pubmed: 32220310
F1000Res. 2019 Jul 2;8:1000
pubmed: 31448109
Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60
pubmed: 15150417
Nat Commun. 2014;5:3067
pubmed: 24473083
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
J Virol. 2002 May;76(10):5233-50
pubmed: 11967337
J Virol. 2006 Apr;80(7):3225-37
pubmed: 16537590
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Nat Rev Microbiol. 2009 Mar;7(3):226-36
pubmed: 19198616
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
J Mol Biol. 2017 Dec 8;429(24):3875-3892
pubmed: 29056462
Virology. 2018 Apr;517:3-8
pubmed: 29275820
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
Science. 2005 Sep 16;309(5742):1864-8
pubmed: 16166518
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Virus Res. 2008 Jul;135(1):107-14
pubmed: 18403041

Auteurs

Ayal B Gussow (AB)

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894.

Noam Auslander (N)

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894; noam.auslander@nih.gov koonin@ncbi.nlm.nih.gov.

Guilhem Faure (G)

Broad Institute of MIT and Harvard, Cambridge, MA 02142.

Yuri I Wolf (YI)

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894.

Feng Zhang (F)

Broad Institute of MIT and Harvard, Cambridge, MA 02142.
Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA 02139.
McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139.
Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.

Eugene V Koonin (EV)

National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD 20894; noam.auslander@nih.gov koonin@ncbi.nlm.nih.gov.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH